This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Qi, C. et al. Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results. Nat. Med. https://doi.org/10.1038/s41591-022-01800-8 (2022)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ray, K. Promising phase I interim results for CAR T cells in gastrointestinal cancers. Nat Rev Gastroenterol Hepatol 19, 416 (2022). https://doi.org/10.1038/s41575-022-00640-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41575-022-00640-8